FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4287958806> ?p ?o ?g. }

• W4287958806 abstract "This study aimed to investigate whether renin-angiotensin system inhibitors (RAS-I) have an advantage over calcium channel blockers (CCB) for suppression of proteinuria in hypertensive patients with gastric cancer receiving ramucirumab (RAM) treatment. Adult Japanese patients with gastric cancer who were outpatients at Asahikawa Medical University Hospital, National Hospital Organization Hokkaido Cancer Center, and Iwate Medical University Hospital between July 1, 2015, and March 31, 2021, were included in this study. Of these patients, those who had received first-time RAM treatment, and those treated with antihypertensive agents including RAS-I or a CCB at initial RAM administration were included. A total of 36 patients were analyzed in this study. Of these patients, 17 patients were classified into the RAS-I group and the remaining 19 into the CCB group. After 12 weeks of RAM administration, the prevalence of proteinuria in the RAS-I group was significantly lower than that in the CCB group. Additionally, Kaplan-Meier analysis showed that the cumulative occurrence of proteinuria in the RAS-I group over 12 weeks following RAM administration was significantly lower than that in the CCB group. Furthermore, simulation of the time course of RAM blood concentrations based on the O'Brien model showed that there may not be differences in the RAM blood concentration profiles over 12 weeks between the two groups. RAS-I may have an advantage over CCB for suppressing proteinuria in hypertensive patients with gastric cancer treated with blood pressure antihypertensive agents. Our results provide useful information to healthcare professionals involved in the administration of RAM treatment." @default.
• W4287958806 created "2022-07-26" @default.
• W4287958806 creator A5013192729 @default.
• W4287958806 creator A5023871696 @default.
• W4287958806 creator A5030643567 @default.
• W4287958806 creator A5031796522 @default.
• W4287958806 creator A5038527025 @default.
• W4287958806 creator A5039859624 @default.
• W4287958806 creator A5042932125 @default.
• W4287958806 creator A5045287676 @default.
• W4287958806 creator A5063440891 @default.
• W4287958806 creator A5064164202 @default.
• W4287958806 creator A5071395567 @default.
• W4287958806 creator A5074318638 @default.
• W4287958806 date "2022-07-26" @default.
• W4287958806 modified "2023-10-18" @default.
• W4287958806 title "Renin‑angiotensin system inhibitors may have an advantage over calcium channel blockers in reducing proteinuria in gastric cancer patients receiving ramucirumab" @default.
• W4287958806 cites W1602318159 @default.
• W4287958806 cites W1787464747 @default.
• W4287958806 cites W1967841898 @default.
• W4287958806 cites W1987254109 @default.
• W4287958806 cites W2002986768 @default.
• W4287958806 cites W2005502601 @default.
• W4287958806 cites W2017849671 @default.
• W4287958806 cites W2048152656 @default.
• W4287958806 cites W2052066839 @default.
• W4287958806 cites W2073342125 @default.
• W4287958806 cites W2081569453 @default.
• W4287958806 cites W2087554021 @default.
• W4287958806 cites W2097805169 @default.
• W4287958806 cites W2112231282 @default.
• W4287958806 cites W2128545033 @default.
• W4287958806 cites W2152189242 @default.
• W4287958806 cites W2168020089 @default.
• W4287958806 cites W2171998177 @default.
• W4287958806 cites W2619939224 @default.
• W4287958806 cites W2735208690 @default.
• W4287958806 cites W2746633526 @default.
• W4287958806 cites W2753841357 @default.
• W4287958806 cites W2777339059 @default.
• W4287958806 cites W2791347437 @default.
• W4287958806 cites W2797581153 @default.
• W4287958806 cites W2897722020 @default.
• W4287958806 cites W2955189017 @default.
• W4287958806 cites W2966611464 @default.
• W4287958806 cites W3021985029 @default.
• W4287958806 cites W3133743921 @default.
• W4287958806 cites W2944030597 @default.
• W4287958806 doi "https://doi.org/10.3892/br.2022.1559" @default.
• W4287958806 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35950098" @default.
• W4287958806 hasPublicationYear "2022" @default.
• W4287958806 type Work @default.
• W4287958806 citedByCount "0" @default.
• W4287958806 crossrefType "journal-article" @default.
• W4287958806 hasAuthorship W4287958806A5013192729 @default.
• W4287958806 hasAuthorship W4287958806A5023871696 @default.
• W4287958806 hasAuthorship W4287958806A5030643567 @default.
• W4287958806 hasAuthorship W4287958806A5031796522 @default.
• W4287958806 hasAuthorship W4287958806A5038527025 @default.
• W4287958806 hasAuthorship W4287958806A5039859624 @default.
• W4287958806 hasAuthorship W4287958806A5042932125 @default.
• W4287958806 hasAuthorship W4287958806A5045287676 @default.
• W4287958806 hasAuthorship W4287958806A5063440891 @default.
• W4287958806 hasAuthorship W4287958806A5064164202 @default.
• W4287958806 hasAuthorship W4287958806A5071395567 @default.
• W4287958806 hasAuthorship W4287958806A5074318638 @default.
• W4287958806 hasBestOaLocation W42879588061 @default.
• W4287958806 hasConcept C121608353 @default.
• W4287958806 hasConcept C126322002 @default.
• W4287958806 hasConcept C2779551604 @default.
• W4287958806 hasConcept C2779561371 @default.
• W4287958806 hasConcept C2780091579 @default.
• W4287958806 hasConcept C2781018059 @default.
• W4287958806 hasConcept C29537977 @default.
• W4287958806 hasConcept C71924100 @default.
• W4287958806 hasConcept C84393581 @default.
• W4287958806 hasConcept C90924648 @default.
• W4287958806 hasConceptScore W4287958806C121608353 @default.
• W4287958806 hasConceptScore W4287958806C126322002 @default.
• W4287958806 hasConceptScore W4287958806C2779551604 @default.
• W4287958806 hasConceptScore W4287958806C2779561371 @default.
• W4287958806 hasConceptScore W4287958806C2780091579 @default.
• W4287958806 hasConceptScore W4287958806C2781018059 @default.
• W4287958806 hasConceptScore W4287958806C29537977 @default.
• W4287958806 hasConceptScore W4287958806C71924100 @default.
• W4287958806 hasConceptScore W4287958806C84393581 @default.
• W4287958806 hasConceptScore W4287958806C90924648 @default.
• W4287958806 hasIssue "3" @default.
• W4287958806 hasLocation W42879588061 @default.
• W4287958806 hasLocation W42879588062 @default.
• W4287958806 hasLocation W42879588063 @default.
• W4287958806 hasOpenAccess W4287958806 @default.
• W4287958806 hasPrimaryLocation W42879588061 @default.
• W4287958806 hasRelatedWork W1787464747 @default.
• W4287958806 hasRelatedWork W2064384290 @default.
• W4287958806 hasRelatedWork W2396218464 @default.
• W4287958806 hasRelatedWork W2794334948 @default.
• W4287958806 hasRelatedWork W2953707545 @default.
• W4287958806 hasRelatedWork W3034856000 @default.
• W4287958806 hasRelatedWork W3188231199 @default.

• next